Product labelling is at the core of the pharmaceutical industry's impending digital transformation. The European Union's shift to Electronic Product Information (ePI) is altering how pharmaceutical businesses handle package inserts, regulatory updates, patient communication, and packaging operations as healthcare systems become more digital. Regulatory, medical affairs, artwork, and packaging teams see ePI as a chance to modernize labelling procedures, enhance patient access to information, and develop a more flexible packaging strategy, rather than just a compliance necessity. To that end, World BI organizes Pharma Packaging & Labelling conferences that bring together suppliers and manufacturers, enabling them to choose the best partner to meet the right partner for their packaging and labelling needs.
Electronic Product Information: What is It?
The digital equivalent of the conventional paper package inserts included with pharmaceuticals is called Electronic Product Information (ePI).
Approved product information, including as prescribing information, patient leaflets, dosage directions, warnings, and safety updates, can be made digitally accessible through standardized electronic forms rather than depending exclusively on printed leaflets.
The project is being developed throughout Europe to facilitate the quicker dissemination of authorized regulatory updates while supporting uniform, organized, and machine-readable product information.
The goal is to build a networked environment where patients, regulators, pharmaceutical companies, and healthcare professionals can access the most recent authorized information at any time, rather than just digitizing records.
Why the EU is Moving Toward Digital Labelling?
Operational difficulties with traditional printed packaging inserts have long existed. Artwork changes, reprinting, inventory management, and market coordination are frequently necessary for every safety update, wording change, or regulatory variance. Critical changes are implemented more slowly and at a higher cost as a result of these operations.
To overcome these obstacles, digital labelling makes it possible for:
- Implementing authorized safety modifications more quickly.
- Enhanced patient and healthcare provider accessibility.
- Improved multilingual information administration.
- Decreased reliance on printed records.
- Increased uniformity among European marketplaces.
Pharmaceutical businesses are getting ready for a future in which digital product information will be a crucial component of product lifecycle management as regulatory frameworks continue to change.
How Packaging Operations are Being Transformed by ePI
A More Dynamic Approach to Artwork Management
Revisions brought on by changes in regulations are typically handled by artwork teams. Organizations can improve version control and free up artwork teams to concentrate on packaging optimization, serialization, and branding by using digital product information to decrease the quantity of printed leaflet revisions.
Quicker Management of Regulatory Change
Regulatory approvals can result in significant package changes for several SKUs and nations. Organizations may publish authorized information more quickly using digital labelling, which shortens implementation times and minimizes operational impact.
Multilingual Packaging Made Easy
Packaging complexity has always been a result of Europe's bilingual market. Electronic product information supports more effective regional operations by offering a scalable method of supplying country-specific language material without appreciably increasing package variety.
Improved Experience for Patients
Patients are expecting more and more digital access to healthcare information. Users can utilize smartphones or other connected devices to access the most recent approved product information, larger font sizes, accessibility features, and updated safety information using digital platforms and QR codes. In addition to helping patients with language or vision difficulties, this enhances usability.
The Expanding Function of Connected Packaging and QR Codes
QR codes are becoming a crucial part of pharmaceutical packaging as digital labelling grows. QR codes are increasingly being used as entrances to more than just advertisements.
- Inserts for electronic packages.
- Current safety data.
- Resources for education.
- Instructions for administration.
- Verification of the product.
- Information about products that have been approved by regulations
Pharmaceutical packs are changing from static labels to dynamic information platforms that facilitate patient involvement and compliance thanks to connected packaging.
Challenges Organizations Need to Get Ready for
Despite the significant advantages, ePI implementation necessitates meticulous preparation across several corporate domains. Organizations have a number of important problems to overcome:
Cross-Functional Cooperation: Regulatory Affairs, Medical Affairs, Packaging, Artwork, Quality Assurance, IT, and Supply Chain teams must work closely together to ensure successful deployment.
Data Regulation: Strong data management procedures and well-defined governance frameworks are necessary to maintain accurate, authorized, and synchronized digital product information.
Technology Integration: To effectively support ePI, many businesses will need to integrate digital publishing solutions, artwork management platforms, document management systems, and regulatory systems.
Worldwide Coordination: In order to preserve global consistency, businesses that operate globally must manage the disparities between European digital labelling programs and legal requirements in other locations.
Advantages of Strategy Beyond Compliance
Pharmaceutical companies with an eye on the future see ePI as more than just a legal requirement.
Measurable business value can be produced by digital labelling through:
- Cutting down on the number of artwork revision cycles.
- Increasing the authorized updates time to market.
- Endorsing eco-friendly packaging projects.
- Reducing the cost of printing and leaflet management.
- Improving patient access to reliable data.
- Increasing operational adaptability along product lines.
Businesses that start planning now will be in a better position to adjust as digital labelling spreads.
Getting Ready for Medicinal Packaging's Future
The transition to electronic product information is a reflection of a larger trend toward smarter packaging ecosystems and digital healthcare.
Professionals in packaging should start assessing:
- Current artwork management processes.
- Digital publishing capabilities.
- Implementation strategies for QR codes.
- Workflows for changing regulations.
- Data governance structures.
- Models of interdisciplinary cooperation.
One of the biggest shifts in pharmaceutical labelling in recent years is the switch to Electronic Product Information (ePI). The long-term advantages go well beyond compliance, even if execution will necessitate cooperation between the regulatory, medical affairs, packaging, artwork, and technology teams.
Organizations that update their labelling strategy now will be more equipped for tomorrow's regulatory environment, smarter packaging operations, and more connected patient experiences as the pharmaceutical industry embraces digital transformation.
Join the Discussion at Pharma Packaging & Labelling Forum (PPL) Europe 2027
The future of pharmaceutical packaging is being molded by cooperative problem-solving, changing regulations, and digital innovation. The Pharma Packaging & labelling Forum Europe 2027 provides the chance to hear directly from industry leaders, regulatory experts, and packaging professionals if your company is getting ready for ePI implementation, digital labelling, artwork modernization, or next-generation packaging strategies.
Participate in the discussion to learn about real-world case studies, innovative technology, and useful tactics that are shaping the future of pharmaceutical packaging in Europe.
For more information, feel free to call, message, or email us at World BI.